Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

High-grade Gliomas.

Nayak L, Reardon DA.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1548-1563. doi: 10.1212/CON.0000000000000554. Review.

PMID:
29200110
2.

Chemotherapy in glioma.

Taal W, Bromberg JE, van den Bent MJ.

CNS Oncol. 2015;4(3):179-92. doi: 10.2217/cns.15.2. Epub 2015 Apr 23. Review.

3.

Adults with newly diagnosed high-grade gliomas.

Croteau D, Mikkelsen T.

Curr Treat Options Oncol. 2001 Dec;2(6):507-15. Review.

PMID:
12057096
4.

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.

Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M.

J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9. Erratum in: J Clin Oncol. 2010 Feb 1;28(4):708.

PMID:
19901110
5.

Malignant gliomas.

Burton EC, Prados MD.

Curr Treat Options Oncol. 2000 Dec;1(5):459-68. Review.

PMID:
12057153
6.

Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.

Chen R, Cohen AL, Colman H.

Curr Treat Options Oncol. 2016 Aug;17(8):42. doi: 10.1007/s11864-016-0418-0. Review.

PMID:
27334978
7.

Anaplastic gliomas in adults: an update.

Izquierdo C, Joubert B, Ducray F.

Curr Opin Oncol. 2017 Nov;29(6):434-442. doi: 10.1097/CCO.0000000000000409. Review.

PMID:
28901965
8.

Evidence-based adjuvant therapy for gliomas: current concepts and newer developments.

Khan MK, Hunter GK, Vogelbaum M, Suh JH, Chao ST.

Indian J Cancer. 2009 Apr-Jun;46(2):96-107. Review.

9.

The Role of Molecular Diagnostics in the Management of Patients with Gliomas.

Wirsching HG, Weller M.

Curr Treat Options Oncol. 2016 Oct;17(10):51. doi: 10.1007/s11864-016-0430-4. Review.

PMID:
27501915
10.

Current management of low-grade gliomas.

Hottinger AF, Hegi ME, Baumert BG.

Curr Opin Neurol. 2016 Dec;29(6):782-788. Review.

PMID:
27676279
11.

[The Role of Chemotherapy in the Treatment of Low-grade Gliomas].

Lakomý R, Kazda T, Poprach A, Pospíšil P, Jančálek R, Šlampa P.

Klin Onkol. Fall 2017;30(5):343-348. doi: 10.14735/amko2017343. Review. Czech.

PMID:
29031036
12.
13.

Chemotherapy for treatment of grade II gliomas.

Strowd RE 3rd, Holdhoff M, Grossman SA.

Oncology (Williston Park). 2014 Dec;28(12):1036-43. Review.

14.

Low-grade gliomas.

Schiff D.

Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):345-54. doi: 10.1212/01.CON.0000464174.88687.79. Review.

PMID:
25837900
15.

Molecular targeted therapies and chemotherapy in malignant gliomas.

Brandsma D, van den Bent MJ.

Curr Opin Oncol. 2007 Nov;19(6):598-605. Review.

PMID:
17906459
16.

Low-grade gliomas.

Stieber VW.

Curr Treat Options Oncol. 2001 Dec;2(6):495-506. Review.

PMID:
12057095
17.

Recurrent malignant glioma in adults.

Tatter SB.

Curr Treat Options Oncol. 2002 Dec;3(6):509-24. Review.

PMID:
12392640
18.

Low-grade Gliomas.

Schiff D.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1564-1579. doi: 10.1212/CON.0000000000000537. Review.

PMID:
29200111
19.

Anaplastic glioma.

Paleologos NA, Merrell RT.

Curr Treat Options Neurol. 2012 Aug;14(4):381-90. doi: 10.1007/s11940-012-0177-6.

PMID:
22665140
20.

[Clinicopathological diagnosis of gliomas by genotype analysis].

Nakamura M, Shimada K, Nakase H, Konishi N.

Brain Nerve. 2009 Jul;61(7):773-80. Review. Japanese.

PMID:
19618854

Supplemental Content

Support Center